Huang Jinke, Liu Jiali, Wang Fengyun, Tang Xudong
Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Postdoctoral Research Station, China Academy of Chinese Medical Sciences, Beijing, China.
Syst Rev. 2024 Jul 16;13(1):183. doi: 10.1186/s13643-024-02591-4.
Growing numbers of randomized clinical trials-based systematic reviews and meta-analyses (SRs/MAs) have been conducted to examine the effectiveness of acupuncture in treating gastroesophageal reflux disease (GERD). An overview of SRs/MAs will be conducted with the aim of systematically compiling, evaluating, and synthesizing the evidence regarding acupuncture for GERD.
SRs/MAs of acupuncture on GERD will be searched in eight databases. Two independent reviewers will conduct the literature search, data extraction, and review quality assessment. Utilizing the AMSTAR-2 tool, PRISMA checklists, and GRADE system, respectively, the methodological quality, reporting quality, and evidence quality will be evaluated. In relation to the subject and the overview's objects, the results will be given. This study will aid in identifying gaps between evidence and its clinical application and serve as a roadmap for further high-quality research.
The results of the overview will aid in closing the gap between clinical evidence and its use in clinical practice. This study will identify significant faults in the use of evidence, point out areas where methodology needs to be improved, and provide guidance for future high-quality research.
PROSPERO CRD42022371850.
Ethics approval is not necessary because no personal information about individuals is collected. A peer-reviewed journal or pertinent conferences will publish the results, whichever comes first.
越来越多基于随机临床试验的系统评价和荟萃分析(SRs/MAs)被开展,以检验针刺治疗胃食管反流病(GERD)的有效性。将进行一项SRs/MAs的概述,目的是系统地汇编、评估和综合有关针刺治疗GERD的证据。
将在八个数据库中检索关于针刺治疗GERD的SRs/MAs。两名独立的评审员将进行文献检索、数据提取和综述质量评估。分别使用AMSTAR-2工具、PRISMA清单和GRADE系统,对方法学质量、报告质量和证据质量进行评估。针对主题和综述目的给出结果。本研究将有助于识别证据与其临床应用之间的差距,并为进一步的高质量研究提供路线图。
概述的结果将有助于缩小临床证据与其在临床实践中的应用之间的差距。本研究将识别证据使用中的重大缺陷,指出方法学需要改进的领域,并为未来的高质量研究提供指导。
PROSPERO CRD42022371850。
由于未收集个人的个人信息,无需伦理批准。结果将在同行评审期刊或相关会议上发表,以先到者为准。